Sally Ann Burtle, MD
Dermatology · Greenbrae
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 1 carrier
- Offices
- 3
- Since medical school
- 26 years
- Hahnemann University College of Medicine, 2000
Offices
3 locations · Greenbrae Dermatology, A Medical Corporation · Permanente Medical Group Inc
Plans that list them
8 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Burtle’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A94836 · Current
Licensed to practise in California · since 2006 · expires 2027-09-30 · Allegheny University of the Health Sciences-Mcp Hahnemann.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$34,362
Medicare paid this office $34,362 for 169 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 68 | $6,440 | $86 |
| Biopsy of related skin growth, first growth | 49 | $4,725 | $94 |
| Destruction of skin growth, 1-14 growths | 38 | $4,334 | $114 |
| Destruction of precancer skin growth, 1 growth | 67 | $3,543 | $50 |
| New patient visit (30+ min) | 27 | $2,763 | $102 |
See all 9 services
| Short return visit (20+ min) | 68 | $6,440 | $86 |
| Biopsy of related skin growth, first growth | 49 | $4,725 | $94 |
| Destruction of skin growth, 1-14 growths | 38 | $4,334 | $114 |
| Destruction of precancer skin growth, 1 growth | 67 | $3,543 | $50 |
| New patient visit (30+ min) | 27 | $2,763 | $102 |
| Short return visit | 42 | $2,485 | $54 |
| Return visit (30+ min) | 14 | $1,715 | $123 |
| Biopsy of related skin growth, each additional growth | 18 | $1,239 | $52 |
| Destruction of precancer skin growth, 2-14 growths | 42 | $1,222 | $7 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 615 | More than 89% of doctors who do this |
| Skin biopsy | 225 | More than 87% of doctors who do this |
Who their Medicare patients are
169 Original Medicare patients in 2024. Average age 76 · Women 63% · Health risk score 0.88. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 50% · Cancer 21% · Coronary heart disease 18% · Atrial fibrillation 15% · Chronic kidney disease 14% · Depression 14% · Diabetes 9% · Stroke 8% · Heart failure 7% · COPD 7%.
The office billed $91,274, Medicare allowed $43,898 and paid $34,362; for 574 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$10,861
Pharmacies billed $10,861 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 111) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
107 generic and fewer than 11 brand-name prescriptions · $10,861 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Triamcinolone Acetonide | 22 | $359 | $16 |
| Fluocinonide | 12 | $225 | $19 |
Year by year
| 2024 | 111 | 69 | 0% (0) | None | $10,861 |
| 2023 | 97 | 52 | 0% (0) | 24% | $57,983 |
| 2022 | 107 | 75 | 0% (0) | None | $4,210 |
| 2021 | 160 | 108 | 0% (0) | 17% | $44,432 |
| 2020 | 655 | 286 | 0% (0) | 13% | $161,626 |
| 2019 | 810 | 343 | 0% (0) | 19% | $180,578 |
| 2018 | 738 | 353 | 0% (0) | 23% | $169,137 |
| 2017 | 787 | 360 | 0% (0) | 25% | $141,359 |
| 2016 | 823 | 342 | 0% (0) | 31% | $261,115 |
| 2015 | 827 | 324 | 0% (0) | None | $261,228 |
| 2014 | 829 | 296 | None | None | $138,590 |
| 2013 | 1,052 | 353 | None | 23% | $205,253 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Fluorouracil | 16 | $727 | $45 |
| Triamcinolone Acetonide | 17 | $667 | $39 |
2022: 3 drugs
| Fluorouracil | 19 | $1,070 | $56 |
| Triamcinolone Acetonide | 25 | $666 | $27 |
| Fluocinonide | 11 | $451 | $41 |
2021: 4 drugs
| Fluocinonide | 23 | $1,132 | $49 |
| Fluorouracil | 18 | $1,041 | $58 |
| Clindamycin Phosphate | 11 | $734 | $67 |
| Triamcinolone Acetonide | 12 | $234 | $19 |
2020: 18 drugs
| Pimecrolimus | 14 | $9,467 | $676 |
| Fluorouracil | 76 | $4,815 | $63 |
| Fluocinonide | 59 | $4,418 | $75 |
| Clobetasol Propionate | 45 | $1,876 | $42 |
| Betamethasone Diprop Augmented | 12 | $1,453 | $121 |
| Metronidazole | 41 | $1,353 | $33 |
| Triamcinolone Acetonide | 66 | $1,325 | $20 |
| Retin-A | 18 | $996 | $55 |
| Fluocinolone Acetonide | 13 | $969 | $75 |
| Doxycycline Monohydrate | 21 | $875 | $42 |
| Clindamycin Phosphate | 11 | $607 | $55 |
| Hydrocortisone | 25 | $560 | $22 |
| Alclometasone Dipropionate | 12 | $559 | $47 |
| Gabapentin | 13 | $326 | $25 |
| Prednisone | 18 | $299 | $17 |
| Selenium Sulfide | 11 | $259 | $24 |
| Mupirocin | 20 | $258 | $13 |
| Valacyclovir | 15 | $180 | $12 |
2019: 24 drugs
| Cosentyx Pen (2 Pens) | 12 | $23,493 | $1,958 |
| Pimecrolimus | 12 | $8,949 | $746 |
| Fluorouracil | 75 | $5,779 | $77 |
| Fluocinonide | 51 | $4,686 | $92 |
| Clobetasol Propionate | 45 | $2,980 | $66 |
| Triamcinolone Acetonide | 99 | $2,613 | $26 |
| Betamethasone Diprop Augmented | 22 | $2,370 | $108 |
| Clindamycin Phosphate | 29 | $1,755 | $61 |
| Metronidazole | 49 | $1,570 | $32 |
| Tacrolimus | 11 | $1,426 | $130 |
| Vectical | 12 | $1,354 | $113 |
| Fluocinolone Acetonide | 12 | $1,249 | $104 |
| Retin-A | 23 | $1,159 | $50 |
| Hydrocortisone | 45 | $1,006 | $22 |
| Doxycycline Monohydrate | 23 | $915 | $40 |
| Alclometasone Dipropionate | 18 | $721 | $40 |
| Selenium Sulfide | 18 | $479 | $27 |
| Methotrexate | 17 | $342 | $20 |
| Gabapentin | 14 | $318 | $23 |
| Mometasone Furoate | 13 | $301 | $23 |
| Prednisone | 17 | $268 | $16 |
| Cefadroxil | 14 | $236 | $17 |
| Azithromycin | 13 | $186 | $14 |
| Fluconazole | 14 | $177 | $13 |
2018: 21 drugs
| Cosentyx Pen (2 Pens) | 12 | $21,874 | $1,823 |
| Fluorouracil | 65 | $8,988 | $138 |
| Fluocinonide | 70 | $8,259 | $118 |
| Elidel | 18 | $5,416 | $301 |
| Triamcinolone Acetonide | 84 | $3,112 | $37 |
| Betamethasone Diprop Augmented | 23 | $2,458 | $107 |
| Metronidazole | 43 | $2,008 | $47 |
| Clobetasol Propionate | 21 | $1,930 | $92 |
| Vectical | 17 | $1,798 | $106 |
| Clindamycin Phosphate | 30 | $1,325 | $44 |
| Retin-A | 26 | $1,116 | $43 |
| Doxycycline Monohydrate | 25 | $996 | $40 |
| Alclometasone Dipropionate | 17 | $992 | $58 |
| Selenium Sulfide | 21 | $756 | $36 |
| Methotrexate | 12 | $664 | $55 |
| Hydrocortisone | 19 | $465 | $24 |
| Prednisone | 24 | $451 | $19 |
| Gabapentin | 13 | $377 | $29 |
| Azithromycin | 16 | $338 | $21 |
| Ketoconazole | 11 | $311 | $28 |
| Mometasone Furoate | 14 | $204 | $15 |
2017: 20 drugs
| Fluorouracil | 80 | $14,373 | $180 |
| Fluocinonide | 65 | $9,823 | $151 |
| Econazole Nitrate | 11 | $5,869 | $534 |
| Elidel | 23 | $5,615 | $244 |
| Metronidazole | 46 | $3,436 | $75 |
| Triamcinolone Acetonide | 80 | $3,405 | $43 |
| Clindamycin Phosphate | 30 | $2,487 | $83 |
| Vectical | 23 | $2,433 | $106 |
| Clobetasol Propionate | 19 | $2,353 | $124 |
| Betamethasone Dipropionate | 21 | $1,589 | $76 |
| Alclometasone Dipropionate | 22 | $1,142 | $52 |
| Selenium Sulfide | 23 | $894 | $39 |
| Retin-A | 25 | $887 | $35 |
| Doxycycline Monohydrate | 20 | $697 | $35 |
| Spironolactone | 15 | $661 | $44 |
| Hydrocortisone | 34 | $602 | $18 |
| Azithromycin | 22 | $386 | $18 |
| Mometasone Furoate | 21 | $333 | $16 |
| Gabapentin | 15 | $292 | $19 |
| Prednisone | 14 | $150 | $11 |
2016: 25 drugs
| Enbrel | 15 | $83,932 | $5,595 |
| Humira | 19 | $68,389 | $3,599 |
| Clobetasol Propionate | 27 | $19,917 | $738 |
| Fluocinonide | 88 | $10,183 | $116 |
| Econazole Nitrate | 11 | $9,741 | $886 |
| Fluorouracil | 65 | $7,321 | $113 |
| Triamcinolone Acetonide | 88 | $5,809 | $66 |
| Clindamycin Phosphate | 36 | $3,257 | $90 |
| Betamethasone Dipropionate | 27 | $2,436 | $90 |
| Alclometasone Dipropionate | 34 | $2,248 | $66 |
| Desonide | 12 | $1,685 | $140 |
| Metronidazole | 22 | $1,643 | $75 |
| Vectical | 11 | $1,164 | $106 |
| Selenium Sulfide | 23 | $963 | $42 |
| Doxycycline Monohydrate | 18 | $928 | $52 |
| Retin-A | 23 | $907 | $39 |
| Ketoconazole | 21 | $906 | $43 |
| Methotrexate | 16 | $807 | $50 |
| Nystatin-Triamcinolone | 14 | $640 | $46 |
| Spironolactone | 14 | $608 | $43 |
| Azithromycin | 16 | $422 | $26 |
| Hydrocortisone | 24 | $372 | $15 |
| Mometasone Furoate | 14 | $322 | $23 |
| Valacyclovir | 15 | $255 | $17 |
| Acyclovir | 13 | $170 | $13 |
2015: 23 drugs
| Enbrel | 26 | $140,797 | $5,415 |
| Clobetasol Propionate | 63 | $29,470 | $468 |
| Fluocinonide | 98 | $10,506 | $107 |
| Econazole Nitrate | 25 | $10,170 | $407 |
| Triamcinolone Acetonide | 83 | $5,339 | $64 |
| Desonide | 41 | $4,292 | $105 |
| Fluorouracil | 37 | $4,211 | $114 |
| Clindamycin Phosphate | 29 | $4,021 | $139 |
| Tazorac | 11 | $2,993 | $272 |
| Betamethasone Dipropionate | 19 | $2,942 | $155 |
| Doxycycline Monohydrate | 25 | $1,775 | $71 |
| Metronidazole | 20 | $1,652 | $83 |
| Retin-A | 30 | $1,274 | $42 |
| Selenium Sulfide | 27 | $1,270 | $47 |
| Minocycline | 12 | $930 | $77 |
| Nystatin-Triamcinolone | 17 | $787 | $46 |
| Ketoconazole | 22 | $732 | $33 |
| Methotrexate | 15 | $604 | $40 |
| Spironolactone | 13 | $602 | $46 |
| Fluconazole | 22 | $497 | $23 |
| Hydroxyzine | 12 | $456 | $38 |
| Azithromycin | 11 | $385 | $35 |
| Hydrocortisone | 11 | $195 | $18 |
2014: 21 drugs
| Enbrel | 15 | $54,218 | $3,615 |
| Acitretin | 22 | $16,434 | $747 |
| Fluocinonide | 106 | $7,614 | $72 |
| Triamcinolone Acetonide | 89 | $6,335 | $71 |
| Vectical | 19 | $5,130 | $270 |
| Clobetasol Propionate | 84 | $4,993 | $59 |
| Desonide | 22 | $2,869 | $130 |
| Clindamycin Phosphate | 31 | $2,795 | $90 |
| Fluorouracil | 19 | $2,162 | $114 |
| Doxycycline Monohydrate | 25 | $2,148 | $86 |
| Metronidazole | 26 | $2,024 | $78 |
| Minocycline | 17 | $1,406 | $83 |
| Selenium Sulfide | 30 | $1,358 | $45 |
| Methotrexate | 13 | $1,276 | $98 |
| Hydrocortisone Butyrate | 18 | $1,183 | $66 |
| Econazole Nitrate | 14 | $974 | $70 |
| Nystatin-Triamcinolone | 13 | $922 | $71 |
| Retin-A | 36 | $919 | $26 |
| Ketoconazole | 23 | $625 | $27 |
| Hydroxyzine | 11 | $482 | $44 |
| Hydrocortisone | 19 | $355 | $19 |
2013: 25 drugs
| Enbrel | 28 | $102,757 | $3,670 |
| Soriatane | 15 | $15,686 | $1,046 |
| Fluocinonide | 125 | $10,270 | $82 |
| Triamcinolone Acetonide | 118 | $9,284 | $79 |
| Clobetasol Propionate | 112 | $3,823 | $34 |
| Metronidazole | 30 | $3,043 | $101 |
| Betamethasone Dipropionate | 22 | $2,917 | $133 |
| Desonide | 34 | $2,903 | $85 |
| Clindamycin Phosphate | 33 | $2,877 | $87 |
| Doxycycline Hyclate | 31 | $2,438 | $79 |
| Fluorouracil | 13 | $2,229 | $171 |
| Retin-A | 64 | $1,766 | $28 |
| Minocycline | 25 | $1,551 | $62 |
| Selenium Sulfide | 31 | $1,346 | $43 |
| Hydrocortisone Butyrate | 20 | $1,310 | $66 |
| Nystatin-Triamcinolone | 12 | $1,084 | $90 |
| Methotrexate | 15 | $812 | $54 |
| Hydroxyzine | 21 | $668 | $32 |
| Ketoconazole | 17 | $483 | $28 |
| Econazole Nitrate | 14 | $424 | $30 |
| Hydrocortisone | 17 | $352 | $21 |
| Mupirocin | 11 | $321 | $29 |
| Spironolactone | 11 | $218 | $20 |
| Prednisone | 15 | $153 | $10 |
| Fluconazole | 11 | $115 | $10 |
Money from drug and device companies
$971 in 2025
| 2025 | 10 | 31 | None | $971 |
| 2024 | 5 | 8 | None | $302 |
| 2022 | 1 | 1 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Cibinqo | $242 | 7 payments
|
| Galderma Laboratories L.P. | Nemluvio | $238 | 6 payments
|
| Ucb | Bimzelx | $127 | 4 payments
|
| Novartis Pharmaceuticals | Rhapsido | $98 | 4 payments
|
| Lilly USA | Taltz | $58 | 2 payments
|
| Incyte | Opzelura | $58 | 2 payments
|
See all 31 published payments
| Incyte | Meals · 2025-12-11 | Opzelura | $30 |
| Ucb | Meals · 2025-12-04 | Bimzelx | $35 |
| Galderma Laboratories L.P. | Meals · 2025-11-26 | Nemluvio | $20 |
| Biofrontera | Meals · 2025-11-19 | None | $30 |
| LEO Pharma | Meals · 2025-11-17 | Anzupgo | $20 |
| Novartis Pharmaceuticals | Meals · 2025-11-12 | Rhapsido | $25 |
| Galderma Laboratories L.P. | Meals · 2025-11-06 | Nemluvio | $31 |
| Pfizer | Meals · 2025-10-30 | Cibinqo | $29 |
| Novartis Pharmaceuticals | Meals · 2025-10-13 | Rhapsido | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-06 | Rhapsido | $18 |
| Incyte | Meals · 2025-09-18 | Opzelura | $28 |
| Ucb | Meals · 2025-09-10 | Bimzelx | $30 |
| Pfizer | Meals · 2025-09-10 | Cibinqo | $17 |
| Arcutis Biotherapeutics | Meals · 2025-09-08 | Zoryve | $24 |
| LEO Pharma | Meals · 2025-09-03 | Adbry | $15 |
| Galderma Laboratories L.P. | Meals · 2025-08-12 | Nemluvio | $2 |
| Galderma Laboratories L.P. | Meals · 2025-08-12 | Nemluvio | $26 |
| Pfizer | Meals · 2025-08-05 | Cibinqo | $20 |
| Galderma Laboratories L.P. | Meals · 2025-07-31 | Nemluvio | $29 |
| Pfizer | Meals · 2025-07-16 | Cibinqo | $26 |
| Ucb | Meals · 2025-07-10 | Bimzelx | $36 |
| Biofrontera | Meals · 2025-06-25 | None | $26 |
| Ucb | Meals · 2025-05-07 | Bimzelx | $26 |
| Lilly USA | Meals · 2025-04-23 | Taltz | $30 |
| Pfizer | Meals · 2025-04-15 | Litfulo | $104 |
| Galderma Laboratories L.P. | Meals · 2025-04-03 | Nemluvio | $130 |
| Novartis Pharmaceuticals | Meals · 2025-03-26 | Cosentyx | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Dupixent | $36 |
| Pfizer | Meals · 2025-03-05 | Cibinqo | $29 |
| Pfizer | Meals · 2025-03-05 | Cibinqo | $16 |
| Lilly USA | Meals · 2025-01-01 | Taltz | $29 |
See earlier years (2024, 2022)
2024: $302
| Pfizer | Cibinqo | $172 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $38 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $32 | 1 payment
|
| Lilly USA | Taltz | $32 | 1 payment
|
| Abbvie | Rinvoq | $28 | 1 payment
|
2022: $29
| Regeneron Healthcare Solutions | Dupixent | $29 | 1 payment
|
Professional record
- NPI
- 1821093972
- Licence
- CA A94836, PA MD422621California A94836: Current · expires 2027-09-30
- Trained
- Hahnemann University College of Medicine, 2000 · 26 years ago
- Group
- Greenbrae Dermatology, A Medical Corporation · Permanente Medical Group Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 901 Nevin Ave, Richmond, CA, 94801
- NPI first listed
- 2005-06-16
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.